@FierceMedDev: Med tech M&A beware: Top Senate Democrats reveal plan to crack down on inversions. Article | Follow @FierceMedDev
@VarunSaxena2: ICYMI: ACLA head makes case against FDA LDT regulation to Congress. Story | Follow @VarunSaxena2
@MichaelGFierce: ICYMI: UO, Berkeley team tailors ultrathin peptoid nanosheets for delivery using oil and water. FierceDrugDelivery story | Follow @MichaelGFierce
@EmilyWFierce: Top Senate Democrats unveil plans to curb corporate tax inversions. Reuters story | Follow @EmilyWFierce
> Google's research division, Google X, acquired Lift Labs, a medical deivce company focused on neurodegenerative diseases and maker of the tremor-canceling spoon. Story
> Medtronic ($MDT) received 510(k) clearance from FDA for its NC Euphora Noncompliant Balloon Dilatation Catheter. Release
> India's Apollo Hospitals and AlivCor have teamed up to bring AliveCor's smartphone enabled heart monitor to arrhythmia patients South Asia. Release
> Tops Comprehensive Breast Center in Houston released data from a recent study concluding that digital breast tomosynthesis and full-field digital mammography is a better cancer detection screening tool than full-field digital mammography alone. Story
Biotech News
@FierceBiotech: Gates Foundation adds $50M to help speed Ebola drug development efforts. Story | Follow @FierceBiotech
@JohnCFierce: Analysts: Pfizer execs say they're locked-and-loaded on tax inversion, and open to targets - via @TracyStaton. Article | Follow @JohnCFierce
@DamianFierce: Biotech's sprawling PED scandal widens as @adamfeuerstein admits that he "juices" daily. Report | Follow @DamianFierce
@EmilyMFierce: Uh oh. Survival rate of Ebola may be less than what we think. More from Science | Follow @EmilyMFierce
> Baxalta: Baxter's newly named biopharma spinout has had its ups and downs. Article
> Virobay tees up a $50M IPO to get a trio of candidates into Phase II. More
> Sanofi keeps the faith in MS and eyes a new dawn for Genzyme. News
Pharma News
@FiercePharma: Immunotherapy vaccine combo cuts recurrence in HER2 breast cancer patients. News | Follow @FiercePharma
@EricPFierce: Merck & Co is again shipping BCG vaccine but Sanofi is not. Story | Follow @EricPFierce
@CarlyHFierce: FDA approves Sanofi's Menactra as meningococcal booster. More | Follow @CarlyHFierce
> Takeda preps to launch Orexigen's obesity drug Contrave as Novo's Saxenda looms. Story
> Meet Baxalta, the pharma spinoff Baxter plans to unleash in 2015. Article
Vaccines News
> Glaxo's Ebola vaccine passes key animal test as human trials begin. News
> Immunotherapy vaccine combo cuts recurrence in HER2 breast cancer patients. More
> New problems at GSK flu vaccine plant will impact U.S., Canada orders. Story
> Takeda on track for dengue vaccine nods in 2017-18. Article
> FDA approves Sanofi's Menactra as meningococcal booster. Item
Pharma Manufacturing News
> Apotex recalls Paxil tainted at GSK plant. Story
> Sources: FDA inspectors in Sun plant that has had recalls. More
> FDA fight with compounder tests its patience and its limits. Article
> Hospira will prep Indian workers at Vizag 'university.' Story
> Merck again shipping BCG cancer treatment but Sanofi still is not. Report